Similar articles

• Proceedings: Butaclamol in the treatment of schizophrenia--a comparison of two treatment methods.

  Imaz F, Ban TA, Lehmann HE. Imaz F, et al. Psychopharmacol Bull. 1976 Jan;12(1):31-4. Psychopharmacol Bull. 1976. PMID: 1826 Clinical Trial. No abstract available.
• The effect of a protriptyline-perphenazine combination in chronic psychiatric patients.

  St-Jean A, Ban TA, Scott J. St-Jean A, et al. Curr Ther Res Clin Exp. 1966 Oct;8(10):483-6. Curr Ther Res Clin Exp. 1966. PMID: 4961168 Clinical Trial. No abstract available.
• Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.

  Spivak B, Kosower N, Zipser Y, Shreiber-Schul N, Apter A, Tyano S, Weizman A. Spivak B, et al. Clin Neuropharmacol. 1994 Feb;17(1):83-8. Clin Neuropharmacol. 1994. PMID: 8149362
• Studies on the effectiveness of antidepressant drugs.

  Smith A, Traganza E, Harrison G. Smith A, et al. Psychopharmacol Bull. 1969 Mar:Suppl:1-53. Psychopharmacol Bull. 1969. PMID: 4898337 Review. No abstract available.
• NOSIE--30: history and current status of its use in pharmacopsychiatric research.

  Honigfeld G. Honigfeld G. Mod Probl Pharmacopsychiatry. 1974;7(0):238-63. doi: 10.1159/000395079. Mod Probl Pharmacopsychiatry. 1974. PMID: 4606856 Review. No abstract available.